Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Sir chris odonnel

563 views

Published on

Future Medical Technologies

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

Sir chris odonnel

  1. 1. S ir C h r is R etired C hief E xecutive, Smith & N ephew O ’ D o n n e llF u t u r e M e d ic a l T e c h n o lo g ie s a n d D r iv e r s
  2. 2. F E S T IV A L S H E F F I E L D 2 0 12 Medical Technology Innovative high-value added manufacturing technologySir Christopher O’DonnellMarch 2012
  3. 3. 1970’s 1990’s• High speed clinical chemistry analyser •Hydrocellular wound dressings• Servo-control infant incubator • Lightweight fracture casting products• Portable human isolation nursing system • High vapour permeable IV dressings • ‘Easy to use’ orthopaedic implant instruments Medical Technology Innovation – Personal History1980’s 2000’s• Infection control urinary catheter • Tissue engineered wound dressings• Integrated heart by-pass oxygenator • Oxidised zirconium hips/knees& tube packs • Bio-resorbable arthroscopic fixation Sir Christopher O’Donnell – Sheffield 2012
  4. 4. Healthcare system demands innovationM a r k e t d y n a m ic s V a lu e a d d e d in n o v a t io n s• Demographics• Active lifestyle • Smarter materials• Better-informed patients • Less invasive (MIS) procedures• Declining surgeon income • Accelerated healing• Nurse shortage • Alternative therapies• Healthcare Spending • Faster patient turn-round• Specialization • Positive health economics• New technologies • Ease/convenience of use Sir Christopher O’Donnell – Sheffield 2012
  5. 5. Global Medical Technology Market by Region 2011 Global Market Value: $250bnSource: Espciom 2011 Sir Christopher O’Donnell – Sheffield 2012
  6. 6. to innovate / differentiate products 1. D i f f e r e n c e s i n c u s t o m e r d e m a n d :- • Levels of healthcare spend per capita • Approval, procurement and reimbursement practicesSource: Arthur D Little/ DTI report 2004 Sir Christopher O’Donnell – Sheffield 2012
  7. 7. Factors affecting national ability to innovate / differentiate products Ø A c c e s s t o s c i e n t i f i c /c l i n i c a l k n o w le d g e : - • Varies according to maturity of technology Increasing Technology Maturity • Clinicians have multiple linkages with innovation Embryonic Growth Mature Ageing process IV Diagnostics reagents Orthopaedics Market Size Active wound First“product” management Imaging breakthrough Advanced wound Elec.med/respiratory Radiotherapy management (Tissue engineering) TimeSource: Arthur D Little/ DTI report 2004 Sir Christopher O’Donnell – Sheffield 2012
  8. 8. MedTech Innovation• Medical technology is a large and growing global industry• Innovation is the key driver of growth and is global in nature• Technology plays a major role in driving this innovation – but needs strong industry / clinician / health service collaboration to succeed Sir Christopher O’Donnell – Sheffield 2012
  9. 9. MedTech Sector in the UK UK Yorkshire Region Companies - 150Companies - 2,500+ Turnover - £1.8bnDomestic Market - £6bn Strengths - WoundcareExports - £5bn+ Orthopaedic Devices Surgical InstrumentsEmployees - 50,000 Sir Christopher O’Donnell – Sheffield 2012
  10. 10. Example of Innovation: Knee Joint Replacement SMITH & NEPHEW GENESIS II Knee Systemwith Oxinium™ Technology Sir Christopher O’Donnell – Sheffield 2012
  11. 11. OXINIUM™ – a major innovation in reducing wear • Ceramic is generally accepted as the ideal bearing surface for total joints but has strength limitations• For more than 15 years Smith & Nephew worked to develop an innovative material that combines the benefits of ceramic with the strength of metal• The result OXINIUM™, a metal with an integral ceramic surface• Performing clinically equivalent to or better than conventional alternative Cobalt Chrome• In the Laboratory OXINIUM™ wear at 30 years is less than Cobalt Chrome at 3 years Sir Christopher O’Donnell – Sheffield 2012
  12. 12. Manufacturing Process DevelopmentProcess IssuesDefine & Prove Alloy Biocompatibility Scale Up and Small scale novel alloyProve Smelting Net Shape No other Manufacturer Forging forges Zirconium Shaping & Zirconium dust combusts Grinding Process spontaneously and burns at 3,000°C Finishing & Completely novel mirror Polishing Processes finish requirements Sir Christopher O’Donnell – Sheffield 2012
  13. 13. innovationM a r k e t d y n a m ic s O X IN IU M• Demographics • Smarter materials• Active lifestyle • Less invasive (MIS) procedures• Better-informed patients • Accelerated healing• Declining surgeon income • Alternative therapies• Nurse shortage • Faster patient turn-round• Healthcare Spending • Positive health economics• Specialization • Ease/convenience of use• New technologies Sir Christopher O’Donnell – Sheffield 2012
  14. 14. More Information?• INDUSTRY OVERVIEW Strengths and Opportunity: Annual Update Dec 2011 HMG; www.bis.gov.uk• LOCAL INDUSTRY NETWORK/ASSISTANCE Medilink Yorkshire & Humber Ltd www.medilink.co.uk Telephone: 01142 329200• INNOVATION IN THE HEALTH SERVICE Devices for Dignity (D4D) Healthcare Technology Co-Operative Sheffield Teaching Hospital www.devicesfordignity.org.uk Sir Christopher O’Donnell – Sheffield 2012
  15. 15. F E S T IV A L S H E F F I E L D 2 0 12 Medical Technology Innovative high-value added manufacturing technologySir Christopher O’DonnellMarch 2012

×